Home > News > Recent cases

Napp v Dr Reddy’s and Sandoz Ltd [2016] EWCA Civ 10531 November 2016James Abrahams QC and Henry Ward represented the Appellant, Napp, in this appeal concerning Napp’s patent for a transdermal patch for delivery of the analgesic drug buprenorphine. At first instance the judge had held that the patches produced by the Defendants, Dr Reddy’s and Sandoz, did not infringe Napp’s patent because they used patches with […]
Thoratec v Aachen Innovative Solutions [2016] EWHC 2637 (Pat)26 October 2016Daniel Alexander QC appeared for the Claimant, Thoratec, and James Mellor QC for the Defendant, AIS, in this action concerning AIS’s patents for a catheter device involving a magnetic ‘clutch’. Thoratec initially sought to invalidate both patents in their entirety and later sought a declaration of non-infringement by reference to a Product Description. Thoratec claimed […]
Sony v SSH [2016] EWHC 2584 (Pat)16 October 2016Andrew Lykiardopoulos QC and James Abrahams QC appeared for the Claimants and Part 20 Defendants in this action dealing with a patent for network communications. The patent in suit was owned by SSH, and related to the use of ‘keepalive’ packets of data when exchanging information between private and public networks through a Network Address […]
Warner Lambert v Generics Ltd, Actavis, Caduceus (Pregabalin) [2016] EWCA Civ 100613 October 2016The Court of Appeal has handed down Judgment on the Pregabalin matter. Richard Meade QC, Adrian Speck QC and Isabel Jamal were instructed by Powell Gilbert for Actavis.
Actavis v ICOS and Lilly [2016] EWHC 1955 (Pat)10 August 2016Members of chambers appeared in this patent action relating to tadalafil, a generic product for treating erectile dysfunction. Actavis, Actelion, Teva and Generics UK (Mylan) sought to “clear the way” in relation to two patents owned by ICOS Corp and of which Eli Lilly and Company were exclusive licencees. Birss J found that EP (UK) […]